Technical Analysis for CLSN - Celsion Corporation

Grade Last Price % Change Price Change
C 2.06 -6.36% -0.14
CLSN closed down 6.36 percent on Friday, February 26, 2021, on 30 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Down
Historical CLSN trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
MACD Bearish Signal Line Cross Bearish -6.36%
1,2,3 Pullback Bullish Bullish Swing Setup -6.36%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -6.36%
Older End-of-Day Signals for CLSN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
20 DMA Support 2 days ago
Down 5% 2 days ago
Fell Below Previous Day's Low 2 days ago
Down 3% 2 days ago
Down 2 % 2 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Celsion Corporation Description

Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of targeted chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. The company develops ThermoDox, a liposomal encapsulation of doxorubicin, which is under Phase III clinical trial for primary liver cancer; under phase II clinical trial for colorectal liver metastasis; and under phase II clinical trial for treatment of recurrent chest wall breast cancer. It has a development, product supply, and commercialization agreement with Yakult Honsha Co. for ThermoDox; and a joint research agreement with Royal Philips Electronics to evaluate the combination of Philips' high intensity focused ultrasound with its ThermoDox to determine the potential of this combination to treat various cancers. The company was founded in 1982 and is based in Lawrenceville, New Jersey.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Cancers Breast Cancer Chemotherapy Treatment Of Breast Cancer Drug Development Ultrasound Antineoplastic Drugs Hepatology Hepatocellular Carcinoma Liver Cancer Metastasis Doxorubicin Philips High Intensity Focused Ultrasound Anthracyclines Teratogens

Is CLSN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.5
52 Week Low 0.43
Average Volume 21,761,574
200-Day Moving Average 1.44
50-Day Moving Average 1.37
20-Day Moving Average 1.99
10-Day Moving Average 2.24
Average True Range 0.39
ADX 56.88
+DI 42.01
-DI 21.54
Chandelier Exit (Long, 3 ATRs ) 2.29
Chandelier Exit (Short, 3 ATRs ) 2.48
Upper Bollinger Band 2.77
Lower Bollinger Band 1.22
Percent B (%b) 0.54
BandWidth 77.92
MACD Line 0.26
MACD Signal Line 0.29
MACD Histogram -0.0312
Fundamentals Value
Market Cap 77.08 Million
Num Shares 37.4 Million
EPS -0.40
Price-to-Earnings (P/E) Ratio -5.16
Price-to-Sales 34.39
Price-to-Book 1.19
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.39
Resistance 3 (R3) 2.40 2.30 2.34
Resistance 2 (R2) 2.30 2.22 2.30 2.32
Resistance 1 (R1) 2.18 2.16 2.13 2.17 2.30
Pivot Point 2.08 2.08 2.06 2.08 2.08
Support 1 (S1) 1.96 2.00 1.91 1.95 1.82
Support 2 (S2) 1.86 1.94 1.86 1.80
Support 3 (S3) 1.74 1.86 1.79
Support 4 (S4) 1.73